U.S. Should Revamp Dialysis Drug Payments, Auditor Says

March 25 (Bloomberg) -- Dialysis centers run by DaVita HealthCare Partners, Fresenius Medical Care and other cos aren’t being paid correctly by the Medicare program because the U.S. is miscalculating drug costs, govt auditors said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.